期刊文献+

2型糖尿病周围神经病变的危险因素分析及与血清C肽水平的相关性研究 被引量:30

The risk factors of type 2 diabetic peripheral neuropathy and its association study with C-peptide
下载PDF
导出
摘要 目的观察2型糖尿病周围神经病变(Diabetic Peripheral Neuropathy,DPN)患者行口服葡萄糖耐量试验后不同时间点血清C肽(C-peptide,CP)水平的变化及临床意义。方法入选176例2型糖尿病患者,根据是否存在DPN分为单纯糖尿病(SDM)组66例和DPN组110例。采用散射比浊法测定血清CP水平,比较两组间临床指标及CP水平,并分析DPN发生的危险因素。结果 (1)两组间单因素比较,DPN组病程、年龄、尿微量白蛋白/肌酐、D-二聚体、空腹血糖、糖化血红蛋白(Hb A1c)水平较SDM组高,DPN组体重指数(BMI)、空腹C肽(Fasting C-peptide,FCP)、胰岛素抵抗指数较SDM组水平低。(2)经重复测量方差分析,两组间C肽无差异,尚未发现时间与组别间存在交互作用,不同时间点进一步做两两比较,各个时间点间差异均有统计学意义,随着时间的延长C肽逐渐上升,2 h达到高峰,3 h下降。(3)Logistic回归分析显示病程、年龄、BMI、Hb A1c、糖尿病肾脏病是DPN发生的独立危险因素。结论 2型糖尿病患者发生DPN时FCP水平下降,口服葡萄糖耐量试验后的SDM与DPN两组间C肽无差异,病程、年龄、BMI、Hb A1c、糖尿病肾脏病是DPN发生的独立危险因素。 Objective To obsearve the level and changes of serum C-peptide( CP) at different time points after oral glucose tolerance test in type 2 diabetic peripheral neuropathy( DPN) patients,and explore the risk factors for DPN.Methods 176 patients with type 2 diabetes were divided into simple type 2 diabetes mellitus( SDM) group( n = 66) and DPN group( n = 110) according to the existing of DPN. The level of serum CP was determined by nephelometry method and compared between two groups as well as clinical parameters; Logistic regession model was used to analyze the risk factors of DPN. Results( 1) Univariate analysis between two groups showed that DPN group had a higher duration,age,urinary A /Cr,D-dimer,FCP,Hb A1 c level than those in SDM group,while a lower BMI,FCP,HOMA-IR level than those in SDM group.( 2) Repeated measures analysis of variance showed that there was no difference between the two groups for CP,we had not yet found there was an interaction between time and group,further pairwise comparison between different time points suggested significant differences,CP increased as time prolonged after OGTT,it reached a peak at two hours then fell down till 3 hours.( 3) Logistic regression analysis showed that duration,age,BMI,Hb A1 c,diabetic kidney disease were independent risk factors of DPN( P〈0. 05). Conclusion The level of FCP decreased when T2 DM patients came up with peripheral neuropathy. There was no difference of C-peptide between SDM group and DPN group after OGTT. Duration,age,BMI,Hb A1 c,diabetic kidney disease are independent risk factors of DPN.
出处 《中风与神经疾病杂志》 CAS 北大核心 2016年第3期234-237,共4页 Journal of Apoplexy and Nervous Diseases
关键词 C肽 糖尿病肾脏病 糖尿病周围神经病变 C-peptide Diabetic kidney disease Diabetic peripheral neuropathy
  • 相关文献

参考文献12

二级参考文献60

  • 1李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:206
  • 2汤正义,张炜,盛宏光,张连珍,张毅,毛羽丰,丁慧英,宁光.神经妥乐平对痛性糖尿病神经病变的治疗作用[J].中国新药与临床杂志,2005,24(4):307-310. 被引量:12
  • 3宁光.糖尿病神经病变的诊断和治疗[J].国际内分泌代谢杂志,2006,26(3). 被引量:107
  • 4侯瑞芳,汤正义,宁光.糖尿病周围神经病变的检查方法及其诊断效率[J].国际内分泌代谢杂志,2006,26(4):270-272. 被引量:41
  • 5Sima AA. Pathological mechanisms involved in diabetic neuropathy: can we slow the process [ J ]. Curr Opin Investig Drugs, 2006, 7 (4) : 324 - 337.
  • 6Ido Y, Vindlgni A, Chang K, et al. Prevention of vascular and neu - ral dysfunction in diabetic rat by C -peptide [ J]. Science, 1997, 277 (5325): 563-566.
  • 7Kamiya H, Zhang W, Ekberg K, et al. C 2 peptide reverses nocicep- tire neuropathy in type 1 diabetes [ J ]. Diabetes, 2006, 55 ( 12 ) : 3581 - 3587.
  • 8Sima AAF, Zhang W, Sugimoto K, et al. C -peptide prevents and improves chronic type 1 diabetic polyneuropathy in the BB/Wor- rat [J]. Diabetologia, 2001 449 (7): 889-897.
  • 9Daniela M, Emilia R, Angela MA, et al. Residual C - peptide secre- tion and endothelial function in patients with type 2 diabetes [J]. Clin- ical Science, 2003, 105 (1) : 113 -118.
  • 10Schiekofer S, Balletshofer B, Andrassy M, et al. Endothelial dys- function in diabetes mellitus [ J ]. Semin Thromb Hemost, 2000, 26 (5) : 503 -511.

共引文献6869

同被引文献239

引证文献30

二级引证文献179

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部